m6A epitranscriptomic modification regulates neural progenitor-to-glial cell transition in the retina

Abstract

N6-methyladenosine (m6A) is the most prevalent mRNA internal modification and has been shown to regulate the development, physiology and pathology of various tissues. However, the functions of the m6A epitranscriptome in the visual system remain unclear. In this study, using a retina-specific conditional knockout mouse model, we show that retinas deficient in Mettl3, the core component of the m6A methyltransferase complex, exhibit structural and functional abnormalities beginning at the end of retinogenesis. Immunohistological and scRNA-seq analyses of retinogenesis processes reveal that retinal progenitor cells (RPCs) and Muller glial cells are the two cell types primarily affected by Mettl3 deficiency. Integrative analyses of scRNA-seq and MeRIP-seq data suggest that m6A fine-tunes the transcriptomic transition from RPCs to Muller cells by promoting the degradation of RPC transcripts, the disruption of which leads to abnormalities in late retinogenesis and compromises the glial functions of Muller cells. Finally, overexpression of m6A-regulated RPC-enriched transcripts in late RPCs partially recapitulates the Mettl3-deficient retinal phenotype. Collectively, our study reveals an epitranscriptomic mechanism governing progenitor-to-glial cell transition during late retinogenesis, which is essential for the homeostasis of the mature retina. The mechanism revealed in this study might also apply to other nervous systems.